MedTrace Logo

PTRG-DES Consortium

NCT04734028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13160

Last updated 2022-03-31

No results posted yet for this study

Summary

The PTRG-DES consortium is a coalition composed of multi-center, real-world registries including CAD patients treated with DES in South Korea. From 9 academic registries in Korea, a total of 13,160 patients were enrolled for this database between July 2003 and August 2018. The aim of the study was to investigate long-term prognostic implications of platelet function and genotypes after DES implantation for significant CAD in South Korea.

Conditions

Interventions

DRUG

Clopidogrel Tablets

DES-treated patients were treated with clopidogrel 75 mg daily and aspirin 100 mg daily

Sponsors & Collaborators

  • Korean Society of Interventional Cardiology

    collaborator UNKNOWN

  • Gyeongsang National University Hospital

    lead OTHER

Principal Investigators

  • Do-Sun Lim, MD, PhD · Korea University Anam Hospital, Korea University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-09
Primary Completion
2018-08-07
Completion
2020-06-30
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734028 on ClinicalTrials.gov